Alerts will be sent to your verified email
Verify EmailSMSLIFE
Haleos Labs
|
Nectar Lifesciences
|
Everest Organics
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
9.57 % | -0.71 % | 12.73 % |
5yr Avg Net Profit Margin
|
4.57 % | -0.63 % | 2.92 % |
Price to Book
|
1.77 | 0.33 | 5.38 |
P/E
|
20.08 | 0.0 | 60.59 |
5yr Avg Cash Conversion Cycle
|
-0.85 Days | 81.28 Days | -87.83 Days |
5yr Average Interest Coverage Ratio
|
4.15 | 0.94 | 3.02 |
5yr Avg ROCE
|
10.58 % | 7.51 % | 19.01 % |
5yr Avg Operating Profit Margin
|
10.06 % | 7.57 % | 6.68 % |
5 yr average Debt to Equity
|
0.54 | 0.73 | 0.84 |
5yr CAGR Net Profit
|
-2.24 % | -31.15 % | -58.15 % |
5yr Average Return on Assets
|
4.11 % | -0.34 % | 3.96 % |
Shareholdings
|
|||
Promoter Holding
|
71.41 % | 44.53 % | 60.78 % |
Share Pledged by Promoters
|
0.0 | 99.6 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
1.56 % | -11.27 % | -13.37 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Haleos Labs
|
Nectar Lifesciences
|
Everest Organics
|
---|